Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNKS.L Regulatory News (CNKS)

  • There is currently no data for CNKS

Board Changes

6 May 2021 15:06

RNS Number : 8269X
Cenkos Securities PLC
06 May 2021
 

6 May 2021

Cenkos Securities plc

("Cenkos" or the "Company")

 

Board Changes

 

Further to the announcement released on 9 December 2020 relating to the retirement of Jim Durkin, Chief Executive Officer, at the forthcoming Annual General Meeting, and the appointment of Julian Morse as the new Chief Executive Officer, the Board is pleased to confirm that Julian's appointment has now received regulatory approval from the Financial Conduct Authority. Julian will be appointed to the position of Chief Executive Officer which will take place immediately following the Company's Annual General Meeting on 12 May 2021.

 

The Board is also pleased to announce that Jeremy Osler's appointment as an Executive Director of the Company, has also received regulatory approval from the Financial Conduct Authority. Jeremy will join the Board immediately following the Company's Annual General Meeting on 12 May 2021.

 

Commenting on the Board changes, Lisa Gordon Non-Executive Chairman said:

 

"On behalf of the Board I would like to pay tribute to Jim Durkin, who has been central to the creation and development of Cenkos over the past 16 years. I have hugely enjoyed working with Jim over the last 12 months on the blueprint for Cenkos' ongoing success and we wish him well in his forthcoming retirement.

 

The appointment of Julian Morse as Chief Executive Officer and wider changes to the senior management team across the Firm, including the appointment of Jeremy Osler to the Board as Executive Director, creates a strong team to lead and take the business forward." 

 

For further information, please contact:

Cenkos Securities plc

Lisa Gordon, Non-Executive Chairman

Julian Morse, Executive Director Tel: 0207 397 8900

 

SPARK Advisory Partners Limited

Matt Davis, Nominated Adviser Tel: 0203 368 3552

 

The Nisse Consultancy - Public relations

Jason Nisse Tel: 07769 688618

Andrew Garfield Tel: 07974 982337

 

 

Additional Information 

The only change to the information previously supplied on 9 December 2020 in respect of Jeremy Osler's appointment as required under Schedule 2(g) of the AIM Rules is that his current interest in the Company's share capital is now made up of:  

 

49,627 Ordinary shares held in an ordinary managed account.

93,470 Ordinary shares held in accordance with the terms and conditions of Company's Deferred Bonus Scheme.

8,274 Ordinary shares held in the Company's Share Incentive Plan.

Option over 44,698 Ordinary shares held under the Company's Save As You Earn Plan. These options are at 40.27pence. These options expire on 30 June 2024.

Option over 40,000 Ordinary shares held under the Company's Share Option Plan. These options are at 73.50 pence, subject to a performance condition, and vest in April 2024.

A nil cost Option over 510,000 Ordinary shares held under the Company's Long Term Incentive Plan. These options are subject to a performance condition and vest equally in April 2024, 2025 and 2026.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAAFMITMTMMBJB
Date   Source Headline
17th Mar 202210:14 amRNSForm 8.5 (EPT/NON-RI)
16th Mar 20228:48 amRNSForm 8.5 (EPT/NON-RI)
14th Mar 20228:27 amRNSForm 8.5 (EPT/NON-RI)
11th Mar 20228:37 amRNSForm 8.5 (EPT/NON-RI)
11th Mar 20228:33 amRNSForm 8.5 (EPT/NON-RI)
10th Mar 20229:23 amRNSForm 8.5 (EPT/NON-RI)
10th Mar 20229:09 amRNSForm 8.5 (EPT/NON-RI)
8th Mar 20221:29 pmRNSForm 8.5 (EPT/NON-RI)
8th Mar 20221:26 pmRNSForm 8.5 (EPT/NON-RI)
8th Mar 20229:01 amRNSForm 8.5 (EPT/NON-RI)
7th Mar 20229:10 amRNSForm 8.5 (EPT/NON-RI)
4th Mar 20229:32 amRNSForm 8.5 (EPT/NON-RI)
3rd Mar 20228:40 amRNSForm 8.5 (EPT/NON-RI)
2nd Mar 20228:35 amRNSForm 8.5 (EPT/NON-RI)
1st Mar 20229:03 amRNSForm 8.5 (EPT/NON-RI)
28th Feb 20229:07 amRNSForm 8.5 (EPT/NON-RI)
25th Feb 20229:27 amRNSForm 8.5 (EPT/NON-RI)
22nd Feb 20228:42 amRNSForm 8.5 (EPT/NON-RI)
21st Feb 20228:44 amRNSForm 8.5 (EPT/NON-RI)
21st Feb 20228:44 amRNSForm 8.5 (EPT/NON-RI)
17th Feb 20228:30 amRNSForm 8.5 (EPT/NON-RI)
15th Feb 20228:40 amRNSForm 8.5 (EPT/NON-RI)
15th Feb 20228:38 amRNSForm 8.5 (EPT/NON-RI)
14th Feb 20229:16 amRNSForm 8.5 (EPT/NON-RI)
11th Feb 20229:24 amRNSForm 8.5 (EPT/NON-RI)
11th Feb 20229:22 amRNSForm 8.5 (EPT/NON-RI)
31st Jan 20229:01 amRNSForm 8.5 (EPT/NON-RI)
28th Jan 20228:34 amRNSForm 8.5 (EPT/NON-RI)
27th Jan 20228:17 amRNSForm 8.5 (EPT/NON-RI)
25th Jan 20229:00 amRNSForm 8.5 (EPT/NON-RI)
25th Jan 20228:55 amRNSForm 8.5 (EPT/NON-RI)
19th Jan 20228:42 amRNSForm 8.5 (EPT/NON-RI)
18th Jan 202210:36 amRNSForm 8.5 (EPT/NON-RI)
23rd Dec 20213:39 pmRNSRenewal of the EBT Share Purchase Plan
8th Dec 20218:56 amRNSForm 8.5 (EPT/NON-RI)
26th Nov 20218:37 amRNSForm 8.5 (EPT/NON-RI)
25th Nov 20219:00 amRNSForm 8.5 (EPT/NON-RI)
2nd Nov 202110:14 amRNSForm 8.5 (EPT/NON-RI)
1st Nov 20219:05 amRNSForm 8.5 (EPT/NON-RI)
29th Oct 20211:40 pmRNSBlock Listing Interim Review
28th Oct 202110:25 amRNSForm 8.5 (EPT/NON-RI)
27th Oct 20219:22 amRNSForm 8.5 (EPT/NON-RI)
26th Oct 20218:49 amRNSForm 8.5 (EPT/NON-RI)
25th Oct 20218:30 amRNSForm 8.5 (EPT/NON-RI)
21st Oct 20218:46 amRNSForm 8.5 (EPT/NON-RI)
9th Sep 20217:00 amRNSInterim Results
3rd Sep 20218:43 amRNSForm 8.5 (EPT/NON-RI)
2nd Sep 20218:31 amRNSForm 8.5 (EPT/NON-RI)
1st Sep 20218:30 amRNSForm 8.5 (EPT/NON-RI)
31st Aug 20219:56 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.